Sirnaomics

In News

Price to book forward of Sirnaomics Ltd. – FWB:V5Z - TradingView

TradingView - Jul 08, 2026

Sirnaomics Secures HKD 138 Million Strategic Investment from Bloomage Biotech - BioPharma APAC

BioPharma APAC - Sep 09, 2025

Opening new frontiers in immuno-oncology with RNAi therapeutics - Nature

Nature - Sep 03, 2022

Sirnaomics concludes Phase I trial of pancreatic cancer treatment - Clinical Trials Arena

Clinical Trials Arena - Jul 01, 2024

Sirnaomics Ltd. Announces Poll Results: Approval of 2026 RSU and Share Option Schemes at Extraordinary General Meeting – Minichart - Minichart

Minichart - Jul 01, 2026

Sirnaomics Completes Phase I Clinical Study of STP707 for Pancreatic Cancer with Strong Safety Profile and Promising Disease Stability - BioPharma APAC

BioPharma APAC - Aug 24, 2025

Coronavirus: China tests AbbVie’s HIV drugs; Sirnaomics to develop drugs - Pharmaceutical Technology

Pharmaceutical Technology - Jan 27, 2020

Sirnaomics nabs a major $105M funding round for next stage of its RNA work - Fierce Biotech

Fierce Biotech - Oct 23, 2020

MoCo biopharma Sirnaomics raises another nine-figure round - The Business Journals

The Business Journals - Jul 06, 2021

Clifford Chance advises Sirnaomics on its Chapter 18A Hong Kong IPO and listing - Clifford Chance

Clifford Chance - Dec 30, 2021

Sirnaomics: a unique, clinical-phase RNA therapeutic innovator on the global stage - Nature

Nature - May 16, 2022

Sirnaomics' Spin-Off RNAimmune Secures $10 Million Seed Financing to Advance its mRNA-Based Vaccine and Therapeutic Development - The Herald-Mail

The Herald-Mail - Apr 21, 2021

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment